Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene.
Studies on the biology and function of human cytomegalovirus (HCMV) genes have been hampered by the limited number of viral mutants available for genetic analyses. We have developed a simple procedure to generate and enrich for HCMV recombinants. By inserting the bacterial neo gene, encoding neomycin/kanamycin phosphotransferase, into the large HCMV DNA genome using homologous recombination, selectable mutants of this complex herpesvirus were isolated for the first time. The synthesis of Neo from the viral genome was used to effectively enrich for recombinant viruses (re-viruses) in permissive culture cells grown in the presence of Geneticin (G418). A quick assay for Neo activity in infected cells, based on phosphorylation of kanamycin (Km), was used to easily identify viral recombinants in the process of screening and isolation. This procedure, not used previously to identify re-viruses, proved to be very useful for screening of large numbers of HCMV recombinants. Analysis of re-virus by Southern blotting revealed that the insertion of the marker gene had resulted in the expected deletion of the open reading frames, TRL 13/14 and UL 1-5, of HCMV. Re-virus was stable and showed no differences in growth kinetics as compared to wild-type (wt) virus. The insertion of a selectable marker gene into the HCMV genome and identification of viral recombinants by the Km phosphorylation assay, as presented here, provides the rationale for effective generation, enrichment and stable propagation of HCMV mutants.
Wolff
D
D
Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, Germany.
Jahn
G
G
Plachter
B
B
D015139:Blotting, Southern; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000235:genetics* / Q000302:isolation & purification; D004279:DNA, Viral; D005798:Genes, Bacterial; D006801:Humans; D007612:Kanamycin / Q000378:metabolism; D019868:Kanamycin Kinase; D016297:Mutagenesis, Site-Directed; D010641:Phenotype; D010766:Phosphorylation; D010770:Phosphotransferases / Q000235:genetics*; D011995:Recombination, Genetic
D004279:DNA, Viral; D007612:Kanamycin; D010770:Phosphotransferases; D019868:Kanamycin Kinase